Using the Multiple Attribute Method for Process Development and Quality Control

More manufacturers are embracing MAM, which simplifies biopharmaceutical product quality testing, and facilitates the measurement and monitoring of critical quality attributes.

In this interview with Biopharm International, Richard Rogers, principal scientist at Just Biotherapeutics and formerly a member of the Amgen team that developed and proved the concept behind MAM, describes the story behind the method, how it is moving from quality control testing into drug development, and how it is helping to guide new product and software development.

Read this article in BioPharm International's Outsourcing Resources 2019 eBook.

Article Details

BioPharm International
eBook: Outsourcing Resources 2019
April 2019
Pages: 12–14

Citation

When referring to this article, please cite it as A. Shanley, "Using the Multiple Attribute Method for Process Development and Quality Control," BioPharm International's Outsourcing Resources eBook (April 2019).

Articles in this issue

over 6 years ago

Article

Navigating the Biologics Wave

over 6 years ago

Article

CMC Due Diligence for Accelerated Biologic Drug Development and Manufacturing

over 6 years ago

Article

Complex and Customized: Manufacturing New Molecular Formats

over 6 years ago

Article

Emerging Therapies Test Existing Bioanalytical Methods

Newsletter

Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.

Subscribe Now!